应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FULC Fulcrum Therapeutics
未开盘 03-10 16:00:00 EDT
2.97
-0.17
-5.41%
盘后
2.97
+0.00
0.00%
17:39 EDT
最高
3.13
最低
2.90
成交量
35.06万
今开
3.11
昨收
3.14
日振幅
7.20%
总市值
1.60亿
流通市值
7,871万
总股本
5,398万
成交额
104.84万
换手率
1.32%
流通股本
2,650万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.41%报2.97美元
市场透视 · 01:02
Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.41%报2.97美元
Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.56%报3.06美元
市场透视 · 03-04
Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.56%报3.06美元
Fulcrum Therapeutics, Inc.2024财年实现净利润-9.73百万美元,同比增加90.00%
市场透视 · 03-01
Fulcrum Therapeutics, Inc.2024财年实现净利润-9.73百万美元,同比增加90.00%
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.95%
市场透视 · 02-25
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.95%
福尔克姆治疗公司第四季度GAAP每股亏损$(0.31),好于预期的$(0.32)
财报速递 · 02-25
福尔克姆治疗公司第四季度GAAP每股亏损$(0.31),好于预期的$(0.32)
Fulcrum Therapeutics(FULC.US):2024年Q4财报实现营收0美元,前值为87.1万美元;每股收益为-0.31美元,前值为-0.40美元,预期值为-0.29美元。
金融界 · 02-25
Fulcrum Therapeutics(FULC.US):2024年Q4财报实现营收0美元,前值为87.1万美元;每股收益为-0.31美元,前值为-0.40美元,预期值为-0.29美元。
Fulcrum Therapeutics, Inc.盘中异动 早盘快速下跌5.49%报4.13美元
市场透视 · 01-13
Fulcrum Therapeutics, Inc.盘中异动 早盘快速下跌5.49%报4.13美元
Fulcrum Therapeutics, Inc.盘中异动 急速拉升5.17%报5.09美元
市场透视 · 01-04
Fulcrum Therapeutics, Inc.盘中异动 急速拉升5.17%报5.09美元
Fulcrum Therapeutics, Inc.盘中异动 早盘急速下挫5.01%
市场透视 · 2024-12-30
Fulcrum Therapeutics, Inc.盘中异动 早盘急速下挫5.01%
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.78%报4.56美元
市场透视 · 2024-12-27
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.78%报4.56美元
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.05%
市场透视 · 2024-12-27
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.05%
Fulcrum Therapeutics, Inc.盘中异动 急速上涨5.21%
市场透视 · 2024-12-21
Fulcrum Therapeutics, Inc.盘中异动 急速上涨5.21%
Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.20%
市场透视 · 2024-12-20
Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.20%
Fulcrum Therapeutics, Inc.盘中异动 早盘大幅拉升5.30%
市场透视 · 2024-12-16
Fulcrum Therapeutics, Inc.盘中异动 早盘大幅拉升5.30%
Fulcrum Therapeutics, Inc.盘中异动 早盘快速跳水5.00%
市场透视 · 2024-12-12
Fulcrum Therapeutics, Inc.盘中异动 早盘快速跳水5.00%
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.21%报4.20美元
市场透视 · 2024-12-09
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.21%报4.20美元
Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.04%
市场透视 · 2024-12-05
Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.04%
Fulcrum Therapeutics, Inc.盘中异动 快速下跌5.15%
市场透视 · 2024-12-03
Fulcrum Therapeutics, Inc.盘中异动 快速下跌5.15%
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.23%
市场透视 · 2024-11-27
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.23%
Fulcrum Therapeutics, Inc.2024财年第三财季实现净利润-21.70百万美元,同比增加9.66%
市场透视 · 2024-11-23
Fulcrum Therapeutics, Inc.2024财年第三财季实现净利润-21.70百万美元,同比增加9.66%
加载更多
公司概况
公司名称:
Fulcrum Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fulcrum Therapeutics, Inc.于2015年8月18日在特拉华州注册成立。他们是一家临床阶段的生物制药公司,致力于改善未满足医疗需求的遗传性疾病患者的生活,最初的重点是罕见疾病。他们开发了一种专有产品引擎,用于系统地识别和验证可能调节基因表达的细胞药物靶点,以治疗遗传定义疾病的已知根本原因。他们正在使用他们的产品引擎来识别可被小分子吸毒的目标,而不管基因错误表达的特定潜在机制。他们已经确定了治疗面肩肱型肌营养不良症(FSHD)和某些血红蛋白病(即镰状细胞病,SCD和b-地中海贫血)的根本原因的药物靶点。
发行价格:
--
{"stockData":{"symbol":"FULC","market":"US","secType":"STK","nameCN":"Fulcrum Therapeutics","latestPrice":2.97,"timestamp":1741636800000,"preClose":3.14,"halted":0,"volume":350619,"hourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"17:39 EDT","volume":4092,"amount":12155.88,"timestamp":1741642748417},"delay":0,"floatShares":26503051,"shares":53979306,"eps":-0.156895,"marketStatus":"未开盘","change":-0.17,"latestTime":"03-10 16:00:00 EDT","open":3.11,"high":3.126,"low":2.9,"amount":1048410.4853538,"amplitude":0.071975,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.156895,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1741680000000},"marketStatusCode":0,"adr":0,"listingDate":1563422400000,"exchange":"NASDAQ","adjPreClose":3.14,"postHourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"17:39 EDT","volume":4092,"amount":12155.88,"timestamp":1741642748417},"volumeRatio":0.868286,"impliedVol":0.6817,"impliedVolPercentile":0.364},"requestUrl":"/m/hq/s/FULC","defaultTab":"news","newsList":[{"id":"2518797203","title":"Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.41%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518797203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518797203?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:02","pubTimestamp":1741626172,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时02分,Fulcrum Therapeutics, Inc.股票出现异动,股价大幅下挫5.41%。截至发稿,该股报2.97美元/股,成交量14.2611万股,换手率0.26%,振幅4.33%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.73%。其相关个股中,Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃,换手率分别为4138.96%、3793.09%、981.72%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc,振幅分别为88.14%、78.32%、54.65%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311010252964060a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311010252964060a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FULC","BK4139","LENZ"],"gpt_icon":0},{"id":"2516677389","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.56%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677389?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:40","pubTimestamp":1741099209,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时40分,Fulcrum Therapeutics, Inc.股票出现波动,股价大幅下跌5.56%。截至发稿,该股报3.06美元/股,成交量8270股,换手率0.02%,振幅1.08%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1106.78%、1100.10%、436.25%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.,振幅分别为37.67%、22.25%、19.21%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224009a25f0785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224009a25f0785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","FULC","LENZ"],"gpt_icon":0},{"id":"2516376038","title":"Fulcrum Therapeutics, Inc.2024财年实现净利润-9.73百万美元,同比增加90.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516376038?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:01","pubTimestamp":1740758461,"startTime":"0","endTime":"0","summary":"3月1日,Fulcrum Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为-9.73百万美元,同比增加90.00%;其中营业收入为80.00百万美元,同比增加2746.98%,每股基本收益为-0.16美元。机构评级:截至2025年3月1日,当前有6家机构对Fulcrum Therapeutics, Inc.目标价做出预测,其中目标均价为5.67美元,其中最低目标价为2.00美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000155a258185d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000155a258185d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","LENZ"],"gpt_icon":0},{"id":"2514906570","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514906570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514906570?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:33","pubTimestamp":1740494027,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时33分,Fulcrum Therapeutics, Inc.股票出现异动,股价快速下跌5.95%。截至发稿,该股报3.48美元/股,成交量9438股,换手率0.02%,振幅4.59%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大,Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为760.67%、470.72%、244.50%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Dominari Holdings Inc.,振幅分别为20.51%、14.67%、11.73%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223347a253879e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223347a253879e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"1132526931","title":"福尔克姆治疗公司第四季度GAAP每股亏损$(0.31),好于预期的$(0.32)","url":"https://stock-news.laohu8.com/highlight/detail?id=1132526931","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132526931?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:30","pubTimestamp":1740486651,"startTime":"0","endTime":"0","summary":"福尔克姆治疗公司报告季度每股亏损$,好于分析师预期的$,超出预期3.13%。相比去年同期每股亏损$,这是22.5%的增长。以上内容来自Benzinga Earnings专栏,原文如下:$Fulcrum Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 3.13 percent. This is a 22.5 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福尔克姆治疗公司第四季度GAAP每股亏损$(0.31),好于预期的$(0.32)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FULC"],"gpt_icon":0},{"id":"2514609364","title":"Fulcrum Therapeutics(FULC.US):2024年Q4财报实现营收0美元,前值为87.1万美元;每股收益为-0.31美元,前值为-0.40美元,预期值为-0.29美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514609364","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514609364?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:11","pubTimestamp":1740485514,"startTime":"0","endTime":"0","summary":"Fulcrum Therapeutics(FULC.US):2024年Q4财报实现营收0美元,前值为87.1万美元;每股收益为-0.31美元,前值为-0.40美元,预期值为-0.29美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25201148381039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","FULC"],"gpt_icon":0},{"id":"2503396586","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘快速下跌5.49%报4.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503396586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503396586?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:36","pubTimestamp":1736778990,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时36分,Fulcrum Therapeutics, Inc.股票出现异动,股价急速下挫5.49%。截至发稿,该股报4.13美元/股,成交量1.1376万股,换手率0.02%,振幅4.12%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.99%。其相关个股中,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为3508.04%、2126.83%、393.32%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.,振幅分别为104.79%、102.87%、61.54%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223630a22040ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223630a22040ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","FULC","BK4139"],"gpt_icon":0},{"id":"2500912386","title":"Fulcrum Therapeutics, Inc.盘中异动 急速拉升5.17%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500912386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500912386?lang=zh_cn&edition=full","pubTime":"2025-01-04 03:19","pubTimestamp":1735931999,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日03时19分,Fulcrum Therapeutics, Inc.股票出现波动,股价急速拉升5.17%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.96%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Scorpius Holdings, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为1807.19%、1706.52%、337.93%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.,振幅分别为143.91%、123.70%、107.01%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104032000a214a1af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104032000a214a1af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","FULC","LENZ"],"gpt_icon":0},{"id":"2495526426","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495526426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495526426?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:35","pubTimestamp":1735569346,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时35分,Fulcrum Therapeutics, Inc.股票出现波动,股价大幅下挫5.01%。截至发稿,该股报4.55美元/股,成交量4.42万股,换手率0.08%,振幅4.70%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vincerx Pharma, Inc.、Polyrizon Ltd.涨幅较大,Nls Pharmaceutics Ltd.、Polyrizon Ltd.、Vincerx Pharma, Inc.较为活跃,换手率分别为690.36%、330.51%、108.55%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Vincerx Pharma, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为52.75%、43.40%、38.72%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223546ab98272d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223546ab98272d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2494988385","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.78%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494988385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494988385?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:31","pubTimestamp":1735309864,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时31分,Fulcrum Therapeutics, Inc.股票出现波动,股价急速跳水5.78%。截至发稿,该股报4.56美元/股,成交量4.3608万股,换手率0.08%,振幅3.72%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.50%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Evaxion Biotech As、Serina Therapeutics, Inc.涨幅较大,Evaxion Biotech As、Scisparc Ltd.、Nucana Plc较为活跃,换手率分别为66.79%、24.25%、14.26%,振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Evaxion Biotech As、Armata Pharmaceuticals, Inc.,振幅分别为38.73%、15.35%、7.92%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122722310495ef7427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122722310495ef7427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","FULC"],"gpt_icon":0},{"id":"2494894814","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494894814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494894814?lang=zh_cn&edition=full","pubTime":"2024-12-27 03:49","pubTimestamp":1735242558,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日03时49分,Fulcrum Therapeutics, Inc.股票出现异动,股价急速拉升5.05%。截至发稿,该股报4.78美元/股,成交量46.4472万股,换手率0.86%,振幅5.93%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Moolec Science Sa C/Wts 、Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃,换手率分别为2211.35%、478.30%、119.28%,振幅较大的相关个股有Moolec Science Sa C/Wts 、Scisparc Ltd.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为264.57%、198.24%、131.78%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227034918a20ad4e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227034918a20ad4e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FULC","LENZ","BK4139"],"gpt_icon":0},{"id":"2493423927","title":"Fulcrum Therapeutics, Inc.盘中异动 急速上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493423927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493423927?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:06","pubTimestamp":1734710775,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时06分,Fulcrum Therapeutics, Inc.股票出现异动,股价急速拉升5.21%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Aptose Biosciences, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为2316.07%、176.30%、84.61%,振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.,振幅分别为173.15%、147.88%、92.48%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100061595ea9e1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100061595ea9e1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC","BK4007","BK4139"],"gpt_icon":0},{"id":"2492102675","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492102675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492102675?lang=zh_cn&edition=full","pubTime":"2024-12-20 02:07","pubTimestamp":1734631653,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日02时07分,Fulcrum Therapeutics, Inc.股票出现异动,股价急速跳水5.20%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.59%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大,Psyence Biomedical Ltd.、Elevai Labs, Inc.、Phio Pharmaceuticals Corp.较为活跃,换手率分别为7998.64%、615.47%、491.29%,振幅较大的相关个股有Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为396.08%、248.84%、185.71%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220020734984cdc65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220020734984cdc65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC","BK4007","BK4139"],"gpt_icon":0},{"id":"2491692770","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘大幅拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692770?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:48","pubTimestamp":1734360488,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时48分,Fulcrum Therapeutics, Inc.股票出现波动,股价大幅拉升5.30%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。其相关个股中,Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Tonix Pharmaceuticals Holding Corp.、Viridian Therapeutics, Inc.涨幅较大,Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃,换手率分别为42.27%、32.80%、30.78%,振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为38.10%、19.33%、19.23%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224808ab7c9ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224808ab7c9ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2490872173","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490872173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490872173?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:07","pubTimestamp":1734016055,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时07分,Fulcrum Therapeutics, Inc.股票出现波动,股价快速跳水5.00%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。其相关个股中,Palisade Bio, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Trevi Therapeutics, Inc.涨幅较大,Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为3045.22%、756.04%、65.77%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Palisade Bio, Inc.,振幅分别为75.86%、71.35%、56.43%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212230735984b9845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212230735984b9845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2490773811","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.21%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490773811","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490773811?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:33","pubTimestamp":1733754810,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时33分,Fulcrum Therapeutics, Inc.股票出现异动,股价大幅上涨5.21%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为2430.16%、23.78%、19.98%,振幅较大的相关个股有Rapport Therapeutics, Inc.、Passage Bio, Inc.、Nkgen Biotech, Inc.,振幅分别为106.84%、105.41%、104.58%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223330a1e0a935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223330a1e0a935&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","FULC","LENZ"],"gpt_icon":0},{"id":"2489214963","title":"Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489214963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489214963?lang=zh_cn&edition=full","pubTime":"2024-12-05 03:44","pubTimestamp":1733341440,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日03时44分,Fulcrum Therapeutics, Inc.股票出现异动,股价大幅跳水5.04%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Exicure, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃,换手率分别为4639.59%、283.99%、144.55%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为548.98%、287.57%、64.57%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205034400a1d45213&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205034400a1d45213&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","FULC"],"gpt_icon":0},{"id":"2488468209","title":"Fulcrum Therapeutics, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488468209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488468209?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:41","pubTimestamp":1733236899,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时41分,Fulcrum Therapeutics, Inc.股票出现波动,股价大幅跳水5.15%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Janux Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.涨幅较大,Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃,换手率分别为132.67%、76.28%、60.87%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.、Senti Biosciences, Inc.,振幅分别为51.13%、24.09%、23.90%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224139abf2fe03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224139abf2fe03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FULC","LENZ","BK4007"],"gpt_icon":0},{"id":"2486351868","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486351868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486351868?lang=zh_cn&edition=full","pubTime":"2024-11-27 03:45","pubTimestamp":1732650303,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日03时45分,Fulcrum Therapeutics, Inc.股票出现波动,股价快速拉升5.23%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,Poseida Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,木薯科学、Elevai Labs, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为57.12%、52.10%、34.32%,振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm Plc C/Wts 10/02/2028 、Lakeshore Biopharma Co., Ltd,振幅分别为85.82%、57.50%、55.39%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127034504abe141e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127034504abe141e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FULC","LENZ","BK4007"],"gpt_icon":0},{"id":"2485108298","title":"Fulcrum Therapeutics, Inc.2024财年第三财季实现净利润-21.70百万美元,同比增加9.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485108298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485108298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291206,"startTime":"0","endTime":"0","summary":"11月23日,Fulcrum Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-21.70百万美元,同比增加9.66%;其中营业收入为0.00美元,每股基本收益为-0.35美元。机构评级:截至2024年11月23日,当前有7家机构对Fulcrum Therapeutics, Inc.目标价做出预测,其中目标均价为5.29美元,其中最低目标价为2.00美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000015abd7b7bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000015abd7b7bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fulcrumtx.com","stockEarnings":[{"period":"1week","weight":-0.0833},{"period":"1month","weight":-0.1951},{"period":"3month","weight":-0.2667},{"period":"6month","weight":-0.6644},{"period":"1year","weight":-0.7319},{"period":"ytd","weight":-0.3681}],"compareEarnings":[{"period":"1week","weight":-0.0397},{"period":"1month","weight":-0.0669},{"period":"3month","weight":-0.07},{"period":"6month","weight":0.0111},{"period":"1year","weight":0.0955},{"period":"ytd","weight":-0.0435}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulcrum Therapeutics, Inc.于2015年8月18日在特拉华州注册成立。他们是一家临床阶段的生物制药公司,致力于改善未满足医疗需求的遗传性疾病患者的生活,最初的重点是罕见疾病。他们开发了一种专有产品引擎,用于系统地识别和验证可能调节基因表达的细胞药物靶点,以治疗遗传定义疾病的已知根本原因。他们正在使用他们的产品引擎来识别可被小分子吸毒的目标,而不管基因错误表达的特定潜在机制。他们已经确定了治疗面肩肱型肌营养不良症(FSHD)和某些血红蛋白病(即镰状细胞病,SCD和b-地中海贫血)的根本原因的药物靶点。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.052045},{"month":2,"riseRate":0.5,"avgChangeRate":-0.009687},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.010168},{"month":4,"riseRate":0.2,"avgChangeRate":-0.189757},{"month":5,"riseRate":0.6,"avgChangeRate":0.060108},{"month":6,"riseRate":0.4,"avgChangeRate":-0.04331},{"month":7,"riseRate":0.6,"avgChangeRate":0.083911},{"month":8,"riseRate":0.5,"avgChangeRate":0.487567},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.171434},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.105879},{"month":11,"riseRate":0.833333,"avgChangeRate":0.258816},{"month":12,"riseRate":1,"avgChangeRate":0.213611}],"exchange":"NASDAQ","name":"Fulcrum Therapeutics","nameEN":"Fulcrum Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulcrum Therapeutics(FULC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulcrum Therapeutics,FULC,Fulcrum Therapeutics股票,Fulcrum Therapeutics股票老虎,Fulcrum Therapeutics股票老虎国际,Fulcrum Therapeutics行情,Fulcrum Therapeutics股票行情,Fulcrum Therapeutics股价,Fulcrum Therapeutics股市,Fulcrum Therapeutics股票价格,Fulcrum Therapeutics股票交易,Fulcrum Therapeutics股票购买,Fulcrum Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulcrum Therapeutics(FULC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}